Abstract
Cadmium is a potent and effective carcinogen in rodents and has recently been accepted by IARC (International Agency for Research on Cancer) as a category 1 carcinogen. Cadmium-induced up‐regulation of intracellular signaling pathways leading to increased mitogenesis is thought to be a major mechanism for the carcinogenic activity following chronic cadmium exposure. In the present study, we found that exposure of cells to cadmium induced significant activation of AP‐1 and all three members of the MAP kinase family in mouse epidermal JB6 cells. The induction of AP‐1 activity by cadmium appears to involve activation of Erks, since the induction of AP‐1 activity by cadmium was blocked by pretreatment of cells with PD98058. Interestingly, the induction of AP‐1 by cadmium was greatly enhanced by the chemical tumor promoter, TPA and the growth factor EGF, but not by ultraviolet C radiation. In vivo studies demonstrated that cadmium could also induce transactivation of AP‐1 in AP‐1‐luciferase report transgenic mice. Considering the role of AP‐1 activation in tumor promotion, the results presented in this study provide a possible molecular mechanism for cadmium‐induced carcinogenesis.
Similar content being viewed by others
References
International Agency for Research on Cancer: Beryllium, cadmium, mercury and exposures in the glass manufacturing industry. IARC Monographs on the evaluation of carcinogenesis. Risks to Humans 58: 41–117, 1993
Degraeve N: Carcinogenic, tertogenic, and mutagenic effects of cadmium. Mutat Res 86: 115–135, 1981
Beyersmann D, Hechtenberg S: Cadmium, gene regulation and cellular signaling in mammalian cells. Toxicol Appl Pharmacol 144: 247–261, 1997
Buzard GS, Kasprzak KS: Possible roles of nitric oxide and redox cell signaling in metal-induced toxicity and carcinogenesis: A review. J Environ Pathol Toxicol Oncol 19: 179–199, 2000
Rossman TG, Roy NK, Lin W-C: Is cadmium genotoxic? In: G.F. Nordberg, R.F.M. Herber, L. Alessio (eds). Cadmium in the Human Environment: Toxicity and Carcinogenicity. International Agency for Research on Cancer, Lyon 22, pp 367–375
Meplan C, Mann K, Hainaut P: Cadmium induced conformational modifications of wide-type p53 and suppresses p53 response to DNA damage in culture cells. J Biol Chem 274: 31663–31670, 1999
Ishikawa T, Igarashi T, Hata K, Fujita T: C-fos induction by heat, arsenite, and cadmium is mediated by a heat shock element in its promoter. Biochem Biophys Res Commun 254: 566–571, 1999
Waalkees MP, Rehm S: Cadmium and prostate cancer. J Toxicol Environ Health 43: 251–269, 1994
Achanzar WE, Achanzar KB, Lewis JG, Webber MM, Waalkees MP: Cadmium induced c-myc, p53, and c-jun expression in normal human prostate epithelial cells as a prelude to apoptosis. Toxicol Appl Pharmacol 164: 291–300, 2000
Abshire MK, Buzard GS, Shiraishi N, Waalkes MP: Induction c-myc and c-jun proto-oncogene expression in rat L6 myoblasts by cadmium in inhibited by zinc preinduction of the metallothionein gene. J Toxicol Environ Health 48: 359–377, 1996
Zheng H, Liu J, Choo KHA, Michalska AE, Klaassen CD: Metallothionein-I and-II knock-out mice are sensitive to cadmium-induced liver mRNA expression of c-jun and p53. Toxicol Appl Pharmacol 136: 229–235, 1996
Ding W, Templeton DM: Stress-activated protein kinase-dependent induction of c-fos by Cd2+ is mediated by MKK7. Biochem Biophys Res Commun 273: 718–722, 2000
Coogan TP, Shiraishi N, Wallkes MP: Minimal basal activity and lack of metal-induced activation of the metallothionein gene correlates with lobe-specific sensitivity to the carcinogenic effects of cadmium in the rat prostate. Toxicol Appl Pharmacol 132: 164–173, 1995
Chuang S-M, Wang I-C, Yang J-L: Role of JNK, p38 and ERK mitogenactivated protein kinases in the growth inhibition and apoptosis induced by cadmium. Carcinogenesis 7: 1423–1432, 2000
Elbirt KK, Whitmarch AJ, Davis RJ, Bonkovsky HL: Mechanism of sodium arsenite-mediated induction of heme oxygenase-1 in hepatoma cells: Role of mitogen-activated protein kinases. J Biol Chem 273: 8922–8931, 2000
Matsuoka M, Igisu H: Activation of c-jun NH2-terminal kinase (JNK/ SAPK) in LLC-PK1cells by cadmium. Biochem Biophys Res Commun 251: 527–532, 1998
Huang C, Ma W-Y, Boden GT, Dong Z: Ultraviolet B-induced activated AP-1 activation does not require epidermal growth factor receptor but is blocked by a dominant negative PKC. J Biol Chem 49: 31262–31268, 1996
Rincon M, Flavell RA: AP-1 transcriptional activity requires both T-cell receptor-mediated and co-stimulatory signals in primary T lymphocytes. EMBO J 13: 4370–4381, 1994
Huang C, Ma W-Y, Dawson MI, Rincon M, Flavell RA, Dong Z: Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid. Proc Natl Acad Sci USA 94: 5826–5830, 1997
Huang C, Ma W-Y, Hanenberger D, Cleary MP, Bowden GT, Dong Z: Inhibition of ultraviolet B-induced activator-protein-1 (AP-1) activity by aspirin in AP-1-luciferase transgenic mice. J Biol Chem 272: 26325–26331, 1997
Huang C, Ma W-Y, Young MR, Colburn N, Dong Z: Shortage of mitogen-activation protein kinase in responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells. Proc Natl Acad Sci USA 95: 156–161, 1998
Snow ET: Metal carcinogenesis: mechanistic implications. Pharmacol Therapeut 53: 31–65, 1992
Piscator M: Role of cadmium in carcinogenesis with special reference to cancer of the prostate. Environ Health Perspect 40: 107–120, 1981
Waalkes MP, Oberdorster G: Cadmium carcinogenesis. In: E.C. Foulkes (ed). Biological Effects of Heavy Metals, vol. 2. CRC Press, Boca Raton, FL, pp 129–158
Angel P, Karin M: The role of Jun, Fos, and the AP-1 complex in cell-proliferation and transformation. Biochim Biophy Acta 1072: 129–157, 1991
Dong Z, Watts RG, Sun Y, Colburn NH: Progressive elevation of AP-1 activity during preneoplastic-to-neoplastic progression as modeled in mouse JB6 cell variants. Int J Oncol 7: 359–364, 1995
Dong, Z, Birrer MJ, Watts RG, Matrisian LM, Colburn NH: Blocking tumor promoter induced AP-1 activity inhibits induced transformation in JB6 cells. Proc Natl Acad Sci USA 91: 609–613, 1994
Huang C, Ma W-Y, Dong Z: Inhibitory effects of ascorbic acid on AP-1 activity and transformation in JB6 cells. Int J Oncol 8: 389–393, 1996
Huang C, Ma W-Y, Hecht SS, Dong Z: Inositol hexaphosphate inhibits cell transformation and AP-1 activation by targeting phosphatidylinositol-3 kinase. Cancer Res 57: 2873–2878
Huang, C, Ma W-Y, Dong Z: Requirement of phosphatidylinositol-3 kinase in epidermal growth factor-induced AP-1 transactivation and transformation in JB6 P+ cells. Mol Cell Biol 16: 6427–6435, 1996
Huang C, Li J, Ma W-Y, Dong Z: JNKs activation is required for JB6 cell transformation induced by TNF-α but not by TPA. J Biol Chem 274: 29672–29676, 1999
Bernstein LR, Colburn NH: AP-1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells. Science 244: 566–569, 1989
Watts RG, Huang C, Young MR, Li JJ, Dong Z, Pennie WD, Colburn NH: Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation. Oncogene 17: 3493–3498, 1998
Angel P, Imagawa M, Chiu R, Stein B, Imbra RJ, Rahmsdorf HJ, Jonat C, Herrlich P, Karin M: Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49: 729–739, 1987
Cohen DR, Curran T: Fra-1: A serum-inducible, cellular immediate-early gene that encodes a fos-related antigen. Mol Cell Biol 8: 2063–2069, 1988
Wilson CL, Heppner KJ, Labosky PA, Hogan BL, Matrisian LM: Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Natl Acad Sci USA 94: 1402–1407, 1997
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Huang, C., Zhang, Q., Li, J. et al. Involvement of Erks activation in cadmium‐induced AP‐1 transactivation in vitro and in vivo. Mol Cell Biochem 222, 141–147 (2001). https://doi.org/10.1023/A:1017953927347
Issue Date:
DOI: https://doi.org/10.1023/A:1017953927347